What to Check in Semax, Selank and Other CNS Research Peptides

What to check in Semax, Selank and similar research peptides: sequence, terminal modifications, net peptide content, storage and verifiable certificates.

Published 28 October 2026

Compounds studied for their activity in the central nervous system are among the harder research materials to source carefully. The published literature is uneven, the naming conventions are inconsistent between suppliers, and the distance between what a vendor prints on a label and what an analytical laboratory can actually confirm is often wider than it first appears. Checking these materials is therefore a question about evidence rather than about the compound itself.

Nothing in this article concerns administration to humans or animals, and no part of it describes preparation for any such purpose. These are questions about material characterisation — identity, composition, stability and documentation — asked before anything reaches a bench.

Identity comes before everything else#

The first question is not how pure a material is but whether it is the molecule named on the vial. Chromatographic purity describes the composition of the sample as separated on the column; it says nothing about whether that principal component is the intended sequence. Those are separate analytical questions and a certificate should answer both separately.

Mass spectrometry is the usual basis for an identity assessment. An observed mass consistent with the expected monoisotopic or average mass of the stated sequence is supporting evidence. It is not conclusive on its own — isomers and sequence permutations can share a mass — but a certificate that reports chromatographic composition without any identity measurement has answered only half the question.

Modified termini change the molecule and often not the name#

This is the single most common source of confusion in this category. Many compounds studied for central nervous system activity exist in several forms: free acid or C-terminal amide, free or N-terminally acetylated. Those modifications change the molecular mass, the chromatographic retention and the stability profile, and they are frequently omitted from a product name entirely.

Two vials bearing the same name can therefore contain genuinely different molecules, both accurately described by that name as commonly used. The only way to resolve it is to read the sequence as written on the certificate, including the terminal notation, and check that the reported mass corresponds. If a supplier cannot state which form was analysed, the material is not characterised for research purposes however good the percentage looks.

Composition, and what a chromatogram does not say#

A reported purity figure is derived from the relative area of the principal peak against the total integrated signal under a stated method. That is informative about detectable, chromatographically resolved related species. It is not a statement about the mass composition of the contents of the vial, and the difference matters more here than in most categories, because peptides of this type are frequently short and frequently supplied as salts.

The distinction between what a purity measurement shows and what a quantification measurement shows is worth understanding properly before reading any certificate; we have written about purity testing versus quantification separately, because conflating the two is the most common reading error we see.

Net peptide content is a different number#

Lyophilised material carries water and counterions. Depending on the synthesis and work-up, residual trifluoroacetate or acetate can account for a meaningful fraction of the dry mass, and short sequences with multiple basic residues carry proportionally more. A sample can be chromatographically clean and still contain substantially less peptide by mass than the vial weight suggests.

Where a certificate reports net peptide content or a quantified amount, that figure answers a question the chromatogram does not. Where it does not, the absence should be understood rather than assumed away. For gravimetric work the quantified figure is the one that matters.

Physical state and what happened before it arrived#

Material characterised correctly at release can still change in transit and in storage. Lyophilised peptides are generally handled cold, kept dry and protected from light, and sequences containing methionine, cysteine or tryptophan are more susceptible to oxidative change than the rest. Repeated freezing and thawing of reconstituted solution is a well-recognised source of loss.

The questions worth asking are ordinary logistics questions: how the material was shipped, how long it was in transit, whether it arrived as a visually intact cake or as a residue on the wall of the vial. Our notes on cold chain shipping and lyophilised handling cover both in more detail.

Documentation that can actually be checked#

A certificate is only evidence if it can be verified independently. That means it should name the issuing laboratory, reference a specific batch, state the analytical method and conditions, and provide some route by which a reader can confirm with the laboratory that the document is genuine and unaltered.

We are re-checking our own certificates and are not publishing them until that is finished. A batch result is what one lot measured; it is not a grade that the next lot inherits.

Where the literature is thinner than the marketing#

This is the part most specific to this category. Several compounds in common circulation have a published evidence base that is small, concentrated in a single research group, or available principally in one language. Some of the most frequently repeated statements about them trace back to a small number of preclinical papers, and the chain of citation is often shorter than the confidence of the claim implies.

Our article on where the evidence comes from sets out the structural problem: in-vitro and animal findings do not transfer across species or across routes without further work, and a literature review that stops at the abstract will systematically overstate what is known. Reading the original methods is tedious and there is no substitute for it.

A short list to work through#

Before a material enters a workflow, it is worth being able to answer each of the following from documents rather than from recollection:

• What sequence is stated, including terminal modifications, and does the reported mass correspond?
• Which laboratory performed the analysis, and can the certificate be verified with them directly?
• Which batch does the certificate describe, and is it the batch named on your order?
• What method and conditions produced the reported figure?
• Is net peptide content reported, or only chromatographic composition?
• How was the material shipped and stored, and what condition did it arrive in?

None of these questions are unusual. They are the ordinary questions asked of any reagent, and the reason they are worth restating for this category is that the supply chain around it is less consistent than for most. Material supplied for laboratory research use only deserves the same documentary scrutiny as any other analytical input, and the certificate is where that scrutiny begins.

Pioneer Research Peptides — UK supplier of research peptides for laboratory use. Ask about batch documentation before you order.

For laboratory research use only — not for human consumption. 18+.